Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.

Frontiers in Immunology
C A ThomsonJ W Schrader

Abstract

Most monoclonal antibodies (mAbs) generated from humans infected or vaccinated with the 2009 pandemic H1N1 (pdmH1N1) influenza virus targeted the hemagglutinin (HA) stem. These anti-HA stem mAbs mostly used IGHV1-69 and bound readily to epitopes on the conventional seasonal influenza and pdmH1N1 vaccines. The anti-HA stem mAbs neutralized pdmH1N1, seasonal influenza H1N1 and avian H5N1 influenza viruses by inhibiting HA-mediated fusion of membranes and protected against and treated heterologous lethal infections in mice with H5N1 influenza virus. This demonstrated that therapeutic mAbs could be generated a few months after the new virus emerged. Human immunization with the pdmH1N1 vaccine induced circulating antibodies that when passively transferred, protected mice from lethal, heterologous H5N1 influenza infections. We observed that the dominant heterosubtypic antibody response against the HA stem correlated with the relative absence of memory B cells against the HA head of pdmH1N1, thus enabling the rare heterosubtypic memory B cells induced by seasonal influenza and specific for conserved sites on the HA stem to compete for T-cell help. These results support the notion that broadly protective antibodies against influenza wo...Continue Reading

Citations

May 21, 2013·Trends in Microbiology·Kanta Subbarao, Yumiko Matsuoka
Jun 6, 2013·Virus Research·Guus F Rimmelzwaan, Jacqueline M Katz
Apr 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yanni WangJohn W Schrader
Dec 19, 2013·PloS One·Boerries BrandenburgRobert H E Friesen
Jun 20, 2014·PLoS Pathogens·Javier G MagadánJonathan W Yewdell
Jul 16, 2015·Expert Review of Vaccines·Adam Kenneth Wheatley, Stephen John Kent
Aug 28, 2013·Current Opinion in Virology·Florian Krammer, Peter Palese
Jul 10, 2013·Current Opinion in Virology·Jonathan W Yewdell
Dec 12, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ruth ChinJoseph Torresi
Dec 4, 2015·Science Translational Medicine·Sarah F AndrewsPatrick C Wilson
Mar 2, 2016·Current Opinion in Virology·Florian Krammer
May 27, 2015·The Journal of Clinical Investigation·Kuan-Ying A HuangAlain R Townsend
Jul 22, 2015·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Carole J Henry Dunand, Patrick C Wilson
Mar 19, 2014·Current Opinion in Immunology·Greg A Kirchenbaum, Ted M Ross
Oct 5, 2013·Antiviral Research·Tracey M DoyleXuguang Li
Mar 19, 2015·BioMed Research International·Anwar M Hashem
Jun 4, 2016·Genome Medicine·Nicolas B Strauli, Ryan D Hernandez
Oct 30, 2016·Current Opinion in Immunology·Karlynn E NeuPatrick C Wilson
Oct 23, 2012·The Journal of Infectious Diseases·Matthew S MillerPeter Palese
Oct 31, 2012·The Journal of Infectious Diseases·Xiao-Song HeHarry B Greenberg
May 1, 2013·Future Virology·James S Testa, Ramila Philip
Jan 10, 2014·Journal of Virology·Florian KrammerRandy A Albrecht
Sep 12, 2014·Journal of Virology·Raffael NachbagauerFlorian Krammer
Sep 28, 2012·Journal of Virology·Timothy J PowellAlain R M Townsend
Jun 20, 2014·Clinical and Vaccine Immunology : CVI·Florian KrammerRebecca J Cox

❮ Previous
Next ❯

Datasets Mentioned

BETA
GQ117044

Methods Mentioned

BETA
phage-display
ELISA
dissection
PCR

Related Concepts

Related Feeds